Q4 2013 13F Holders as of 12/31/2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.7M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
16.9M
-
Shares change
-
0
-
Total reported value, excl. options
-
$79.5M
-
Value change
-
$0
-
Price
-
$4.70
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q4 2013
76 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q4 2013.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.9M shares
of 44.7M outstanding shares and own 37.85% of the company stock.
Largest 10 shareholders include GRANAHAN INVESTMENT MANAGEMENT INC/MA (1.72M shares), BlackRock Institutional Trust Company, N.A. (1.59M shares), DIMENSIONAL FUND ADVISORS LP (1.51M shares), F&C Asset Management plc (1.2M shares), HUSSMAN STRATEGIC ADVISORS, INC. (930K shares), VANGUARD GROUP INC (891K shares), ROYCE & ASSOCIATES LLC (767K shares), BlackRock Fund Advisors (704K shares), Penbrook Management LLC (560K shares), and RENAISSANCE TECHNOLOGIES LLC (489K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.